Connecting the pathology of posttraumatic stress and substance use disorders: monoamines and neuropeptides.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3956107)

Published in Pharmacol Biochem Behav on December 11, 2013

Authors

Nicole M Enman1, Yong Zhang2, Ellen M Unterwald3

Author Affiliations

1: Department of Pharmacology and Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA 19140, USA. Electronic address: nicole.enman@temple.edu.
2: The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA. Electronic address: zhangyo@mail.rxockefeller.edu.
3: Department of Pharmacology and Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA 19140, USA. Electronic address: ellen.unterwald@temple.edu.

Articles cited by this

(truncated to the top 100)

Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry (1995) 30.84

Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22

Post-traumatic stress disorder. N Engl J Med (2002) 6.83

Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75

Beautiful faces have variable reward value: fMRI and behavioral evidence. Neuron (2001) 5.45

A 2-year longitudinal analysis of the relationships between violent assault and substance use in women. J Consult Clin Psychol (1997) 4.48

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37

Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse (1993) 4.13

Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci (2002) 3.89

Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature (1997) 3.76

Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry (2001) 3.69

Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry (2006) 3.55

Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats. Psychopharmacology (Berl) (2004) 3.05

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA (2000) 2.91

Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci (2002) 2.83

Biological studies of post-traumatic stress disorder. Nat Rev Neurosci (2012) 2.78

Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci (2006) 2.74

Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend (2005) 2.67

Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature (1998) 2.57

Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry (1999) 2.49

The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat (2001) 2.48

Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network. Am J Psychiatry (2009) 2.44

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry (1997) 2.22

A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci (1999) 2.16

Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. J Anxiety Disord (2010) 2.05

Substance use and posttraumatic stress disorders: symptom interplay and effects on outcome. Addict Behav (2004) 2.02

The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology (Berl) (2013) 2.01

Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry (1999) 1.96

The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci (1998) 1.91

Symptom improvement in co-occurring PTSD and alcohol dependence. J Nerv Ment Dis (2006) 1.88

Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry (1996) 1.87

A review of neuroimaging studies in PTSD: heterogeneity of response to symptom provocation. J Psychiatr Res (2005) 1.85

Incapacitated rape and alcohol use: a prospective analysis. Addict Behav (2006) 1.75

The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berl) (2007) 1.74

Impulsive choice as a predictor of acquisition of IV cocaine self- administration and reinstatement of cocaine-seeking behavior in male and female rats. Exp Clin Psychopharmacol (2008) 1.72

Auditory startle response in trauma survivors with posttraumatic stress disorder: a prospective study. Am J Psychiatry (2000) 1.65

Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry (1998) 1.62

Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: Implications for screening, diagnosis and treatment. Drug Alcohol Depend (2011) 1.60

CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berl) (1998) 1.58

High-alcohol preferring mice are more impulsive than low-alcohol preferring mice as measured in the delay discounting task. Alcohol Clin Exp Res (2009) 1.57

Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry (2011) 1.53

Stress-restress: effects on ACTH and fast feedback. Psychoneuroendocrinology (1997) 1.51

Genetic and environmental influences on posttraumatic stress disorder, alcohol and drug dependence in twin pairs. Drug Alcohol Depend (2000) 1.51

Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. Curr Opin Investig Drugs (2010) 1.49

Aversive imagery in posttraumatic stress disorder: trauma recurrence, comorbidity, and physiological reactivity. Biol Psychiatry (2009) 1.47

Anxiety sensitivity and self-reported reasons for drug use. J Subst Abuse (1997) 1.47

Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci (2012) 1.44

Single prolonged stress: toward an animal model of posttraumatic stress disorder. Depress Anxiety (2009) 1.44

Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend (2009) 1.42

Common genetic and environmental contributions to post-traumatic stress disorder and alcohol dependence in young women. Psychol Med (2010) 1.39

Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol Psychiatry (2009) 1.38

Dopamine transport function is elevated in cocaine users. J Neurochem (2002) 1.37

Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol Psychiatry (2005) 1.36

The neural networks of inhibitory control in posttraumatic stress disorder. J Psychiatry Neurosci (2008) 1.36

Functional neuroimaging studies of post-traumatic stress disorder. Expert Rev Neurother (2011) 1.33

Toward an animal model of posttraumatic stress disorder. Ann N Y Acad Sci (2006) 1.33

PTSD symptom severity as a predictor of cue-elicited drug craving in victims of violent crime. Addict Behav (2003) 1.32

Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry (1997) 1.31

Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment. Exp Clin Psychopharmacol (2007) 1.29

Cocaine dependence and PTSD: a pilot study of symptom interplay and treatment preferences. Addict Behav (2005) 1.28

The relative and unique contributions of emotion dysregulation and impulsivity to posttraumatic stress disorder among substance dependent inpatients. Drug Alcohol Depend (2012) 1.27

Impaired inhibitory control in recreational cocaine users. PLoS One (2007) 1.24

The use of alcohol and drugs to self-medicate symptoms of posttraumatic stress disorder. Depress Anxiety (2010) 1.24

Neuropeptide Y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence. Biol Psychiatry (2011) 1.22

Altered reward processing in the nucleus accumbens and mesial prefrontal cortex of patients with posttraumatic stress disorder. Neuropsychologia (2008) 1.22

Genetic and environmental influences on the relationship among combat exposure, posttraumatic stress disorder symptoms, and alcohol use. J Trauma Stress (2001) 1.22

Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD. Am J Psychiatry (1990) 1.21

Probing reward function in post-traumatic stress disorder with beautiful facial images. Psychiatry Res (2005) 1.20

Anhedonia and emotional numbing in combat veterans with PTSD. Behav Res Ther (2006) 1.18

Severity of psychosocial stress and outcome of alcoholism treatment. J Abnorm Psychol (1990) 1.16

The association between heroin use and anxiety sensitivity among inner-city individuals in residential drug use treatment. Behav Res Ther (2005) 1.16

Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies. Rev Neurosci (2010) 1.15

Functional neuroimaging of reward circuitry responsivity to monetary gains and losses in posttraumatic stress disorder. Biol Psychiatry (2009) 1.14

Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol Psychiatry (2009) 1.13

Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2. J Neurosci (2011) 1.13

Substance use disorder-PTSD comorbidity. Patients' perceptions of symptom interplay and treatment issues. J Subst Abuse Treat (1998) 1.13

Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry (2000) 1.12

Contributions of serotonin in addiction vulnerability. Neuropharmacology (2011) 1.12

Sex differences in prevalence and comorbidity of alcohol and drug use disorders: results from wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. J Stud Alcohol Drugs (2012) 1.11

Neuropeptide Y levels in ethanol-naive alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure. Alcohol Clin Exp Res (1998) 1.08

The role of anxiety sensitivity and drinking motives in predicting alcohol use: a critical review. Clin Psychol Rev (2010) 1.08

Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology (2011) 1.08

Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99m)Tc]TRODAT-1. Psychopharmacology (Berl) (2012) 1.05

Single prolonged stress disrupts retention of extinguished fear in rats. Learn Mem (2012) 1.03

Rates and symptoms of PTSD among cocaine-dependent patients. J Stud Alcohol (2003) 1.03

Differential patterns of HPA activity and reactivity in adult posttraumatic stress disorder and major depressive disorder. Harv Rev Psychiatry (2009) 1.02

Cocaine use increases [3H]WIN 35428 binding sites in human striatum. Brain Res (1993) 1.01

Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats. Eur J Pharmacol (2001) 1.01

Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder. Psychoneuroendocrinology (2008) 0.98

Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats. Neuroscience (2013) 0.98

Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity. Cereb Cortex (2013) 0.97

Psychosocial animal model of PTSD produces a long-lasting traumatic memory, an increase in general anxiety and PTSD-like glucocorticoid abnormalities. Psychoneuroendocrinology (2012) 0.94

Corticotrophin releasing factor (CRF) induced reinstatement of cocaine seeking in male and female rats. Physiol Behav (2011) 0.94

Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder. Prog Brain Res (2008) 0.94

Neuropeptide Y and posttraumatic stress disorder. Mol Psychiatry (2012) 0.93

Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats. J Neuroendocrinol (1999) 0.93

Social defeat and isolation induce clear signs of a depression-like state, but modest cardiac alterations in wild-type rats. Physiol Behav (2012) 0.92

Baseline functioning among individuals with posttraumatic stress disorder and alcohol dependence. J Subst Abuse Treat (2011) 0.92

Altered locus coeruleus-norepinephrine function following single prolonged stress. Eur J Neurosci (2012) 0.92

Impaired response inhibition in veterans with post-traumatic stress disorder and mild traumatic brain injury. J Int Neuropsychol Soc (2012) 0.92